Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma by Astuti, D, Ricketts, C, Chowdury, R, McDonough, M, Gentle, D, Kirby, G, Schlisio, S, Racliffe, P, Schofield, C, Latif, F, Maher, E

CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma. by McRonald, F, Morris, MR, Gentle, D, Winchester, L, Baban, D, Ragoussis, J, Clarke, N, Brown, MD, Kishida, T, Yao, M, Latif, F, Maher, E

Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility. by Astuti, D, Ricketts, C, Chowdhury, R, McDonough, M, Gentle, D, Kirby, G, Schlisio, S, Kenchappa, R, Carter, B, Kaelin, W, Ratcliffe, P, Schofield, C, Latif, F, Maher, E

Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma. by Morris, MR, Hughes, D, Tian, Y, Ricketts, C, Lau, K, Gentle, D, Shuib, S, Serrano-Fernandez, P, Lubinski, J, Wiesener, MS, Pugh, C, Latif, F, Ratcliffe, P, Maher, E